<DOC>
	<DOCNO>NCT01080729</DOCNO>
	<brief_summary>This prospective , observational multicentric study compare Gonal-f FbM ( fill mass ) dose prescribed doctor Gonal-f FbM dose determine CONSORT ( Consistency r-FSH Starting dose individualized treatment ) calculator .</brief_summary>
	<brief_title>An Observational Study Compare Dose Gonal-fTM FbM Prescribed Doctor With Recommendation Dose Calculator Consort Evaluate Ease Use Pre-filled Pen Gonal-fTM FbM Pen</brief_title>
	<detailed_description>The ovarian stimulation follicle-stimulating hormone ( FSH ) main element success medically assist procreation ( MAP ) technique . The possibility predict poor ovarian response would thus enable doctor proactively define treatment cycle subject expectation . However , difficult select right dose recombinant-human FSH ( r-hFSH ) reach `` acceptable '' number oocyte . A series report , investigator identify different variable associate ovarian response , appear literature develop structure approach aim determine initial Gonal-f dose MAP cycle . After reviewed literature , follow predictive factor present strong correlation ovarian response : - Initial serum FSH premature follicle phase ( day 2-4 cycle ) , - Body mass index ( BMI ; kg/m2 ) , - Age , - Initial number antral follicle ( day 2-4 cycle ) determine ultrasound scan . The relative importance factor judge basis statistical model analysis r-hFSH dose ( Gonal-f international unit [ IU ] ) attribute factor view create guideline determine optimal FSH dose ( use CONSORT dose calculator ) use basis initial predictive characteristics/variables specific subject . The purpose study compare Gonal-f FbM dose prescribed doctor Gonal-f FbM dose determine CONSORT calculator . A short questionnaire use evaluate ease use pre-filled Gonal-f ( FbM ) pen . The dosage administration Gonal-f shall accordance Product Features Summary ( PFS ) current clinical practice center . OBJECTIVES Primary objective : - To study whether Gonal-f FbM dose prescribed doctor different dose recommend CONSORT dose calculator Secondary objective : - To evaluate ease use new generation Gonal-f pen subject - To compare Gonal-f dose finally use dose use previous treatment cycle ( data available ) - To put figure total duration treatment , total quantity gonadotropins take number clinical pregnancy - In case use CONSORT calculator : estimate cancellation due poor response This observational study conduct 8 fertility center Belgium Luxembourg per current clinical practice condition force center . Each center recruit approximately 30 subject reach total approximately 250 subject . The maximum number treatment cycle evaluate project 600 period approximately 6 month . The CONSORT dose calculator make available participating center via secure web site . Each investigator receive user identification password access system . The investigator introduce 4 individual variable subject ( basal FSH , BMI , age number antral follicle [ follicle ≥2mm - &lt; 11mm ] ) CONSORT calculator , determine individualize dose Gonal-f specific subject . If investigator agree dose calculate CONSORT opt another dosage , he/she may indicate directly CRF ( Case Report Form ) . In case , Gonal-f dose base investigator 's advice accordance clinical practice force center . Follicle development shall monitor accordance current clinical practice center diagnostic ultrasound and/or estradiol ( E2 ) dosage local criterion administration human chorionic gonadotropin ( hCG ) reach . Human chorionic gonadotropin administer accordance current clinical practice center reach final oocyte maturation . The date administration hCG ( Ovitrelle ) indicate CRF .</detailed_description>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Female subject start treatment Gonalf basis decision investigator indication recommendation PFS Subjects least 35 year old Gonalf dose administer ( i.e . time introduce individual variable subject CONSORT calculator determine dose ) Subjects BMI &lt; 30 kg/m2 Subjects premature follicle phase ( day 24 ) , basal FSH ≤12 IU/l ( measure center 's laboratory ) Subjects take gonadotropinreleasing hormone ( GnRH ) protocol agonist Subjects consent participate study inform investigator medical history Subjects sign write consent form , stipulate subject could dropout study time without negative consequence future medical treatment Subjects simultaneously participate interventional study Subjects follow concomitant treatment clomifene citrate Subjects present one contraindication describe SPC</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Ovulation induction</keyword>
	<keyword>Ovarian Hyperstimulation Syndrome</keyword>
	<keyword>Multifollicular stimulation</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Sperm injection , intracytoplasmic</keyword>
	<keyword>Fertility</keyword>
</DOC>